Marshall Wace’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Buy |
211,695
+51,951
| +33% | +$344K | ﹤0.01% | 1593 |
|
2025
Q1 | $1.46M | Buy |
159,744
+86,321
| +118% | +$790K | ﹤0.01% | 1513 |
|
2024
Q4 | $771K | Sell |
73,423
-307,404
| -81% | -$3.23M | ﹤0.01% | 1725 |
|
2024
Q3 | $4.55M | Buy |
380,827
+48,536
| +15% | +$580K | 0.01% | 952 |
|
2024
Q2 | $1.91M | Buy |
332,291
+91,843
| +38% | +$528K | ﹤0.01% | 1268 |
|
2024
Q1 | $1.25M | Buy |
240,448
+49,813
| +26% | +$259K | ﹤0.01% | 1358 |
|
2023
Q4 | $1M | Sell |
190,635
-74,314
| -28% | -$392K | ﹤0.01% | 1221 |
|
2023
Q3 | $874K | Buy |
264,949
+194,178
| +274% | +$641K | ﹤0.01% | 1299 |
|
2023
Q2 | $205K | Buy |
+70,771
| New | +$205K | ﹤0.01% | 1812 |
|
2022
Q2 | – | Sell |
-10,440
| Closed | -$147K | – | 2723 |
|
2022
Q1 | $147K | Sell |
10,440
-164,751
| -94% | -$2.32M | ﹤0.01% | 2429 |
|
2021
Q4 | $2.54M | Buy |
+175,191
| New | +$2.54M | ﹤0.01% | 1532 |
|
2021
Q2 | – | Sell |
-20,756
| Closed | -$317K | – | 2136 |
|
2021
Q1 | $317K | Buy |
+20,756
| New | +$317K | ﹤0.01% | 1800 |
|